Amy Wakeham | VP, IR & Corporate Communications |
Mick Farrell | CEO & Director |
Brett Sandercock | CFO |
Rob Douglas | President, COO and Interim President, Sleep & Respiratory Care |
David Pendarvis | Chief Administrative Officer and Global General Counsel |
Steve Wheen | Jarden |
Matt Mishan | KeyBanc |
Gretel Janu | Credit Suisse |
Saul Hadassin | Barrenjoey Capital |
Dan Hurren | MST Marquee |
Mike Matson | Needham |
David Bailey | Macquarie |
Lyanne Harrison | Bank of America |
Craig Wong-Pan | RBC |
Chris Cooper | Goldman Sachs |
Suraj Kalia | Oppenheimer |
Margaret Kaczor | William Blair |
Mathieu Chevrier | Citi |
Steve Wheen | Jarden Limited |
Hello, and welcome to the ResMed First Quarter Fiscal 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to your host, Amy Wakeham, Vice President, Investor Relations and Corporate Communications.